OnCore Login

Return to Trial Database

HCRN-GI98-1

Phase I/II Study of Gemcitabine and Docetaxel in Combination for Unresectable or Metastatic Pancreatic Cancer – GI98-1

Status

Study Completed

Cancer Type(s)

Pancreatic

Study Contact

Publications

Phase II study of gemcitabine and docetaxel in combination for advanced pancreatic cancer
  • BP Schneider, KN Ganjoo, LH Einhorn, J Picus, F Fata, PJ Loehrer, C Stoner
A Phase I Study of Weekly Gemcitabine and Docetaxel in Patients with Advanced Cancer
  • KN Ganjoo, MS Gordon, AB Sandler, RE Warner, K Fife, S Poirier, R Seshadri, PJ Loehrer

Trial Locations

All sites in which the trial HCRN-GI98-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278